Congenital CMV: Difference between revisions

From IDWiki
m (: semantic links)
()
Line 1: Line 1:
== Epidemiology ==
+
==Epidemiology==
   
  +
*Maternal seroconversion in about 2% of pregnancies
* Risk of transmission to fetus
 
  +
**Higher in childcare workers
** '''Primary infection''': 30% risk of congenital CMV; higher risk later in pregnancy, but worse outcomes earlier
 
 
*Risk of transmission to fetus
** Non-primary
 
 
**'''Primary infection''': 30% risk of congenital CMV; higher risk later in pregnancy, but worse outcomes earlier
*** '''Reinfection''': 5% risk
 
 
**Non-primary
*** '''Reactivation''': 1% risk
 
 
***'''Reinfection''': 5% risk
 
***'''Reactivation''': 1% risk
   
== Clinical Presentation ==
+
==Clinical Presentation==
* Mother may have had asymptomatic infection
 
* At birth
 
** [[Causes::Microcephaly]]
 
** [[Causes::Periventricular calcifications]]
 
** [[Causes::Chorioretinitis]]
 
** [[Causes::Sensorineural hearing loss]]
 
** [[Causes::Optic nerve atrophy]]
 
** [[Causes::Hepatosplenomegaly]]
 
** [[Causes::Cytopenias]]
 
* Later
 
** [[Causes::Cognitive deficits]] (7%)
 
** [[Causes::Sensorineural hearing loss]] (20%)
 
   
 
*Mother may have had asymptomatic infection
== Diagnosis ==
 
 
*At birth
 
**[[Causes::Microcephaly]]
 
**[[Causes::Periventricular calcifications]]
 
**[[Causes::Chorioretinitis]]
 
**[[Causes::Sensorineural hearing loss]]
 
**[[Causes::Optic nerve atrophy]]
 
**[[Causes::Hepatosplenomegaly]]
 
**[[Causes::Cytopenias]]
 
*Later
 
**[[Causes::Cognitive deficits]] (7%)
 
**[[Causes::Sensorineural hearing loss]] (20%)
   
 
==Diagnosis==
* In mom, IgM antibodies
 
* In baby, urine PCR within 2 weeks of birth
 
   
 
*In mom, IgM antibodies
== Management ==
 
 
*In baby, urine PCR within 2 weeks of birth
   
 
==Management==
* Treatment is indicated for symptomatic babies
 
** Brain
 
** Hearing
 
** Eye
 
* IV [[Is treated by::ganciclovir]] or PO [[Is treated by::valganciclovir]], for 6 months
 
* Monitor CBC while on therapy
 
   
 
*Treatment is indicated for symptomatic babies
 
**Brain
 
**Hearing
 
**Eye
 
*IV [[Is treated by::ganciclovir]] or PO [[Is treated by::valganciclovir]], for 6 months
 
*Monitor CBC while on therapy
   
 
[[Category:Pediatrics]]
 
[[Category:Pediatrics]]

Revision as of 20:33, 13 July 2020

Epidemiology

  • Maternal seroconversion in about 2% of pregnancies
    • Higher in childcare workers
  • Risk of transmission to fetus
    • Primary infection: 30% risk of congenital CMV; higher risk later in pregnancy, but worse outcomes earlier
    • Non-primary
      • Reinfection: 5% risk
      • Reactivation: 1% risk

Clinical Presentation

Diagnosis

  • In mom, IgM antibodies
  • In baby, urine PCR within 2 weeks of birth

Management

  • Treatment is indicated for symptomatic babies
    • Brain
    • Hearing
    • Eye
  • IV ganciclovir or PO valganciclovir, for 6 months
  • Monitor CBC while on therapy